Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Depreciation & Amortization (CF): 2012-2024

Historic Depreciation & Amortization (CF) for Neurogene (NGNE) over the last 11 years, with Dec 2024 value amounting to $3.2 million.

  • Neurogene's Depreciation & Amortization (CF) changed negligibly% to $800,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 3.98%. This contributed to the annual value of $3.2 million for FY2024, which is 3.03% down from last year.
  • According to the latest figures from FY2024, Neurogene's Depreciation & Amortization (CF) is $3.2 million, which was down 3.03% from $3.3 million recorded in FY2023.
  • Over the past 5 years, Neurogene's Depreciation & Amortization (CF) peaked at $3.3 million during FY2023, and registered a low of $785,000 during FY2020.
  • Over the past 3 years, Neurogene's median Depreciation & Amortization (CF) value was $3.2 million (recorded in 2024), while the average stood at $3.2 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 145.02% in 2022, then fell by 3.03% in 2024.
  • Yearly analysis of 5 years shows Neurogene's Depreciation & Amortization (CF) stood at $785,000 in 2020, then surged by 66.37% to $1.3 million in 2021, then surged by 145.02% to $3.2 million in 2022, then grew by 3.12% to $3.3 million in 2023, then dropped by 3.03% to $3.2 million in 2024.